NCI Alliance for Nanotechnology in Cancer – from academic research to clinical interventions
NCI Alliance for Nanotechnology in Cancer – from academic research to clinical interventions
复制标题
NCI 癌症纳米技术联盟——从学术研究到临床干预
DOI：
--
复制
发表时间：
2019
影响因子：
2.8
通讯作者：
Luisa M Russell
中科院分区：
文献类型：
--
作者：
P. Grodzinski;Christina H. Liu;C. Hartshorn;Stephanie A. Morris;Luisa M Russell
美国国立卫生研究院的国家癌症研究所（NCI）资助并运营了NCI癌症纳米技术联盟-这是一个大型多学科计划，利用分子生物学，肿瘤学，物理学，化学和工程学的交叉研究来开发创新的癌症干预措施。该计划表明，几个科学学科的融合促进了癌症纳米技术的创新和进步，并推动了其临床转化。本文回顾了过去13年的联盟计划运作，并描述了其成果、成功和未来展望。
The National Cancer Institute (NCI) of National Institutes of Health has funded and operated the NCI Alliance for Nanotechnology in Cancer - a large multi-disciplinary program which leverages research at the intersection of molecular biology, oncology, physics, chemistry, and engineering to develop innovative cancer interventions. The program has demonstrated that convergence of several scientific disciplines catalyzes innovation and progress in cancer nanotechnology and advances its clinical translation. This paper takes a look at last thirteen years of the Alliance program operations and delineates its outcomes, successes, and outlook for the future.
影响因子：
17.1
作者：
Hartshorn CM;Bradbury MS;Lanza GM;Nel AE;Rao J;Wang AZ;Wiesner UB;Yang L;Grodzinski P
通讯作者：
Grodzinski P
影响因子：
11.2
作者：
Prabhakar U;Maeda H;Jain RK;Sevick-Muraca EM;Zamboni W;Farokhzad OC;Barry ST;Gabizon A;Grodzinski P;Blakey DC
通讯作者：
Blakey DC